- 譽衡藥業
- 3.130-0.010 (-0.318%)
盈利能力分析
- 11.868
- 12.886
- 7.308
- -16.527
- 2.408
- 8.327
- 7.788
- 3.330
- -6.644
- 0.978
- 11.387
- 10.548
- 4.311
- -8.525
- 1.291
邊際利潤分析
- 46.419
- 53.460
- 58.389
- 56.925
- 57.528
- 15.931
- 11.671
- 6.666
- -8.690
- 3.049
- 16.144
- 11.579
- 7.924
- -7.173
- 5.000
- 14.890
- 9.937
- 4.901
- -9.315
- 1.712
收益指標分析
- 74.716
- 78.232
- 77.354
- -22.987
- 54.757
- 13.784
- -3.077
- -23.404
- 99.959
- -10.831
- 1.515
- -0.409
- 0.979
- -0.151
- -11.540
償債能力分析
- 1.391
- 1.066
- 0.818
- 0.777
- 0.822
- 1.206
- 0.837
- 0.683
- 0.686
- 0.690
- 28.125
- 30.167
- 45.749
- 58.187
- 57.852
- 3.755
- 1.620
- 29.485
- 47.661
- 47.104
- 2,531.999
- 5,981.618
- 234.766
- 107.551
- 110.091
- 253.132
- 228.885
- 115.223
- 68.810
- 69.737
- -508.696
- -264.700
- 6.646
- -4.769
- 2.206
營運能力分析
- 18.780
- 24.346
- 29.737
- 26.273
- 31.902
- 51.694
- 60.111
- 66.682
- 76.131
- 97.426
回顧25 展望26
大國博弈
More